Cargando…
Multiple Sclerosis: Overview of Disease-Modifying Agents
Multiple sclerosis (MS) is a chronic autoimmune disease that usually affects young adults, causing progressive physical and cognitive disability. Since the 1990s, its treatment has been based on parenteral medications known collectively as immunomodulators. This drug class is considered safe and usu...
Autor principal: | Finkelsztejn, Alessandro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197902/ https://www.ncbi.nlm.nih.gov/pubmed/25336899 http://dx.doi.org/10.4137/PMC.S13213 |
Ejemplares similares
-
Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020) -
Galectin-3 prospects as a therapeutic agent for multiple sclerosis
por: Thomas, Laura, et al.
Publicado: (2019) -
Early and severe cognitive impairment in multiple
sclerosis
por: Mendes, Maria Fernanda, et al.
Publicado: (2012) -
Disease Modifying Agents for Multiple Sclerosis
por: Hilas, Olga, et al.
Publicado: (2010) -
Disease-modifying agents in multiple sclerosis
por: Coyle, P. K.
Publicado: (2009)